This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,116.87, is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, a specialty medication. The contract has a firm fixed price pricing type and a completion date of January 6, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems, through its extensive supply chain and distribution capabilities.
Generated 3/16/25, 12:47 AM